SCHEMBL14648914

SCHEMBL14648914

COc1ccc(-n2c3ccccc3c3ccccc32)cc1OBO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ MAPK1 P28482 3/20 0.44
▸ LMNA P02545 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ TUBB4A P04350 1/20 0.39
▸ TUBB P07437 1/20 0.39
▸ TUBA3C P0DPH7 1/20 0.39
▸ TUBA1B P68363 1/20 0.39
▸ TUBA4A P68366 1/20 0.39
▸ TUBB4B P68371 1/20 0.39
▸ TUBB3 Q13509 1/20 0.39
▸ TUBB2A Q13885 1/20 0.39
▸ TUBB8 Q3ZCM7 1/20 0.39
▸ TUBA3E Q6PEY2 1/20 0.39
▸ TUBA1A Q71U36 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18209347 0.86 SMN1; SMN2 (0.50) SMN1; SMN2MAPK1LMNAGAARXFP1
SCHEMBL20252170 0.81 L3MBTL1 (0.41) SMN1; SMN2MAPK1LMNAL3MBTL1KDM4E
SCHEMBL20252174 0.81 L3MBTL1 (0.41) SMN1; SMN2MAPK1LMNAL3MBTL1KDM4E
SCHEMBL10100811 0.79 KDM4E (0.47) SMN1; SMN2MAPK1LMNARXFP1L3MBTL1
SCHEMBL14039032 0.78 ENPP2 (0.49) SMN1; SMN2MAPK1LMNAGAARXFP1
SCHEMBL16521616 0.76 IDO1 (0.47) SMN1; SMN2MAPK1LMNAL3MBTL1KDM4E
SCHEMBL28001656 0.76 SMN1; SMN2 (0.47) SMN1; SMN2MAPK1LMNAL3MBTL1KDM4E
SCHEMBL31495214 0.75 TUBB4A (0.49) SMN1; SMN2MAPK1L3MBTL1KDM4EATM
SCHEMBL11978644 0.74 KDM4E (0.50) SMN1; SMN2LMNAL3MBTL1KDM4EATM
SCHEMBL10066241 0.73 KDM4E (0.53) SMN1; SMN2LMNAL3MBTL1KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 SMN1; SMN2 4618/4885MAPK1 2186/4885LMNA 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback